By Staff writer
Doctors and researchers at the Abu Dhabi Stem Cell Centre have successfully treated 73 patients suffering from infection
A potential treatment for Covid-19, developed by a team of doctors and researchers at the Abu Dhabi Stem Cell Centre (ADSCC), has been granted a patent by the UAE Ministry of Economy.
The treatment involves extracting stem cells from a patient’s own blood and reintroducing them after activating them.
The treatment was administered in the UAE to 73 patients suffering from Covid-19, who have all been successfully treated and cured of the virus by inhaling the treatment into their lungs after it had been nebulised into a fine mist.
It is thought it regenerates lung cells and strengthens the immune response, preventing the Covid-19 infection from causing further damage to healthy cells.
A statement from the Ministry of Health and Prevention (MoHAP), said: "The Ministry is following with great attention the developments of this breakthrough and fully supports the earnest efforts being made by the team of scientists and medical experts from the Ministry and the academia to provide treatment to Covid-19 patients."
The treatment has successfully undergone the initial phase of clinical trials, demonstrating its safety. None of the patients who have received the treatment reported immediate adverse effects and there have been no interactions found with the conventional treatment protocols for Covid-19 patients.
Trials to demonstrate the impact of the treatment are ongoing and are expected to be completed in a couple of weeks.
The Abu Dhabi Stem Cells Centre is a specialist healthcare centre that focuses on cell therapy, regenerative medicine and cutting-edge research on stem cells.